S.R.Y. Medical Services is proud to announce, for the first time in Israel, the launch of 18F-NOTA-OCTREOTIDE, a somatostatin analog labeled with fluorine-18, designed for PET imaging of neuroendocrine tumors (NET).
| 68Ga-DOTA-TATE | 18F-NOTA-TIDE | |
| 68min | 110min | Half life |
| Generator | Cyclotron | Production |
| 836keV | 249keV | Mean positron energy |
| 85-86%a, b | 83-99%a, b | Detection rate |
a Pauwels E., et al. Eur J Nucl Med Mol Imaging. 2020; 47: 3033, b Hou J., et al. EJNMMI Res. 2021; 11: 55
Key Advantages:
- Improved spatial resolution images of fluorine-18 labeled ligands compared to those labeled with gallium-68
- Ideal half-life
- Distribution to distant centers
- High production yields
- Comparable performance to that of 68Ga-DOTA-TATE
